Four-week neoadjuvant 5% imiquimod prior to Mohs micrographic surgery for melanoma in situ: A prospective pilot study. [PDF]
Harvey DT, Latoni DI, Li YH, Anand D.
europepmc +1 more source
Topical Imiquimod for Oral Cavity Leukoplakia and Dysplasia: A Scoping Review. [PDF]
Scharner MK +3 more
europepmc +1 more source
Chromatic hyper Zagreb topological descriptors and QSPR analysis of certain skin cancer drugs. [PDF]
Pavithra R, Ravi Sankar J.
europepmc +1 more source
Clinical Course and Treatment Outcomes of Vulvar Condylomas in Immunocompromised Women: A Retrospective Cohort Study. [PDF]
Fonseca FV +4 more
europepmc +1 more source
Treatment Strategies for Extramammary Paget Disease: A Narrative Review of Current Status and Future Directions. [PDF]
Miyashita A, Fukushima S.
europepmc +1 more source
Successful Treatment of Cutaneous Leishmania infantum Infection with Immunocryosurgery after Failure of the Respective Monotherapies. [PDF]
Barakou O +6 more
europepmc +1 more source
Repigmentation in Vitiligo with Imiquimod Immunopeel: A Therapeutic Paradox. [PDF]
Gowda SK, Mehta N, Mehta N, Gupta S.
europepmc +1 more source
Polyphyllins ameliorate imiquimod-induced psoriatic skin barrier disruption and lesions in mice by inhibiting inflammatory infiltration with accelerated recovery effects. [PDF]
Ren S +10 more
europepmc +1 more source
Two primary melanoma in situ lesions of the vulva: Treatment with imiquimod. [PDF]
Coffel BN, Hall KH, Cowart DWL.
europepmc +1 more source

